TUCSON, Ariz., April 24, 2019 (Newswire.com) - America’s Rehab Campuses (ARC) has announced that it provides medical drug detox services that are proven and safe for helping pregnant women recover from opioid use disorder (OUD). Pregnant women who are dependent on opioids require specialized treatment to reduce the risk of complications, including preterm labor, neonatal abstinence syndrome (NAS) and fetal death. ARC’s new treatment protocol is designed to help pregnant women and their unborn babies experience more positive long-term health outcomes.
The National Institute on Drug Abuse states that a baby is born with NAS every 15 minutes. NAS occurs when a baby becomes dependent on opioids or other substances that are used by the mother during pregnancy. Opioids will pass through the placenta to the baby in the womb to trigger drug dependence. After birth, babies with NAS will go through opioid withdrawal, since they are no longer receiving drugs from the mother.
Symptoms of NAS may include diarrhea, vomiting, excessive and/or high-pitched crying, fever, poor feeding, irritability, slow weight gain and seizures. Babies born with NAS often require neonatal intensive care and stay in the hospital for several weeks or months following birth. Between 2004 and 2014, the number of babies born with NAS in the U.S. increased more than five-fold. NAS remains a serious public health concern and continues to be driven by the country’s worsening opioid epidemic.
“At America's Rehab Campuses, a protocol for treatment of pregnant women with OUD has been developed utilizing a rapid induction of buprenorphine (Subutex),” says Dr. Leonard Ditmanson, Chief Medical Officer of ARC. “This treatment dramatically reduces the dangerous effects of acute opioid withdrawal on the mother and fetus. The result of this protocol improves retention in treatment through the duration of the pregnancy. Although comparative results of the effects on newborns exposed to buprenorphine versus methadone or other OUD treatments are not well studied, evidence shows a dramatic reduction in NAS in babies born to mothers treated with buprenorphine."
The National Institutes of Health reports that buprenorphine is superior to methadone at reducing opioid withdrawal symptoms in infants born with NAS. Pregnant women who are dependent on opioids and receive this medication are shown to require fewer doses and give birth to babies that require shorter hospital stays.
Specialized medical detox services for pregnant women are now available at ARC’s many drug rehab facilities. Drug detox is often combined with therapy and counseling to help women attain education and skills that help them experience a successful, long-term recovery from OUD.
America’s Rehab Campuses is setting the standard for quality and personalized rehabilitation programs across the U.S. Contact us at 833-272-7342 to learn more about our programs and begin the treatment process today. Address: 6944 E. Tanque Verde Road, Tucson, AZ 85715.
Contact: Jason Fritz
Phone: 520-526-1000 Ext. 1012
Source: America's Rehab Campuses